Physician profile
Easter M Johnson
NPI 1043562341
$270.81
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $271.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $49.39 | 2021 | |
| Eisai INC. | $46.21 | 2021 | |
| Ucb, INC. | $37.07 | 2021 | |
| Neurelis, INC. | $30.24 | 2021 | |
| Aquestive Therapeutics, INC. | $22.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.04 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.86 | 2021 | |
| Ironshore Pharmaceuticals INC. | $16.86 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.48 | 2021 | |
| Adlon Therapeutics L.P. | $15.74 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Easter Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.